Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.39 |
| ▸ | HSP90AB1 | P08238 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | RAB9A | P51151 | 3/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.35 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.34 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.34 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.34 |
| ▸ | NQO2 | P16083 | 3/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29362227 | 0.87 | NQO2 (0.37) | HSP90AA1HSP90AB1NPC1MAPTRAB9A | |
| SCHEMBL29565955 | 0.87 | NQO2 (0.37) | HSP90AA1HSP90AB1NPC1MAPTRAB9A | |
| SCHEMBL698217 | 0.87 | NQO2 (0.37) | HSP90AA1HSP90AB1NPC1MAPTRAB9A | |
| SCHEMBL6326361 | 0.87 | LMNA (0.35) | NPC1MAPTRAB9ASMN1; SMN2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL3108310 | 0.84 | NQO2 (0.35) | HSP90AA1HSP90AB1NPC1MAPTRAB9A | |
| SCHEMBL8336073 | 0.84 | SLC6A3 (0.36) | HSP90AA1HSP90AB1NPC1MAPTRAB9A | |
| SCHEMBL2076685 | 0.83 | ABCG2 (0.39) | HSP90AA1HSP90AB1PTGS2TXNRD1TXNRD3 | |
| SCHEMBL27899 | 0.83 | ABCG2 (0.39) | HSP90AA1HSP90AB1PTGS2TXNRD1TXNRD3 | |
| SCHEMBL29352284 | 0.83 | ABCG2 (0.39) | HSP90AA1HSP90AB1PTGS2TXNRD1TXNRD3 | |
| SCHEMBL1043409 | 0.83 | KMT2A (0.39) | NPC1MAPTRAB9ASMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2423290-B1 | COMPOSITION COMPRISING 1-MENTHYL (3S)-3-HYDROXYBUTANOATE FOR STIMULATING SENSE | TAKASAGO PERFUMERY CO LTD (JP) | 2019-05-22 | — | — | EP | disclosed |
| EP-2966054-B1 | METHOD OF PRODUCING OPTICALLY-ACTIVE ALDEHYDE | TAKASAGO PERFUMERY CO LTD (JP) | 2019-01-02 | — | — | EP | disclosed |
| US-10029969-B2 | Method of producing optically-active aldehyde | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2018-07-24 | — | — | US | disclosed |
| US-9796678-B2 | Method for manufacturing optically active compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-10-24 | — | — | US | disclosed |
| EP-2796444-B1 | METHOD FOR PRODUCING HIGH-PURITY CERAMIDE | TAKASAGO PERFUMERY CO LTD (JP) | 2017-03-15 | — | — | EP | disclosed |
| US-20170022162-A1 | METHOD FOR MANUFACTURING OPTICALLY ACTIVE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-01-26 | — | — | US | disclosed |
| US-20160152550-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE 2,3-DIHYDROFARNESAL | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2016-06-02 | — | — | US | disclosed |
| EP-2966054-A1 | METHOD OF PRODUCING OPTICALLY-ACTIVE ALDEHYDE | Takasago International Corporation (JP) | 2016-01-13 | — | — | EP | disclosed |
| US-20150376102-A1 | METHOD OF PRODUCING OPTICALLY-ACTIVE ALDEHYDE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2015-12-31 | — | — | US | disclosed |
| US-20150329452-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE ISOPULEGOL AND OPTICALLY ACTIVE MENTHOL | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2015-11-19 | — | — | US | disclosed |
| EP-1277748-A1 | Process for producing optically active y-Butyrolactone | Takasago International Corporation (JP) | 2003-01-22 | — | — | EP | disclosed |
| US-6492545-B2 | Process for producing optically active alcohol | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-12-10 | — | — | US | disclosed |
| US-20020035283-A1 | Process for producing optically active alcohol | TAKASAGO INTERNATIONAL CORPORATION | 2002-03-21 | — | — | US | disclosed |
| EP-1176135-A1 | Process for producing optically active alcohol | Takasago International Corporation (JP) | 2002-01-30 | — | — | EP | disclosed |
| US-6342644-B1 | MULTISTAGE PROCESS OF HYDROGENATION WITH PHOSPHINE COMPLEX | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-01-29 | — | — | US | disclosed |
| US-20020007094-A1 | Method for producing 1-menthol | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-01-17 | — | — | US | disclosed |
| EP-1153908-A2 | Method for producing 1-menthol | Takasago International Corporation (JP) | 2001-11-14 | — | — | EP | disclosed |
| US-6043380-A | FOR ASYMMETRICALLY HYDROGENATING 4-METHYLENE-2-OXETANONE INTO OPTICALLY ACTIVE 4-METHYL-2-OXETANONE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2000-03-28 | — | — | US | disclosed |
| EP-0955303-A2 | Ruthenium-iodo-optically active phosphine complex | Takasago International Corporation (JP) | 1999-11-10 | — | — | EP | disclosed |
| US-5872273-A | LIGANDS FOR FORMING HYDROGENATION CATALYST COMPLEXES | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1999-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150329452-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE ISOPULEGOL AND OPTICALLY ACTIVE MENTHOL | ACSL3, ACSL6, ALOX5 | HSP90AA1 2163/4885HSP90AB1 2057/4885NPC1 3370/4885 |
| US-10029969-B2 | Method of producing optically-active aldehyde | ALDH3A1, ALDH1A2, ADH1A | HSP90AA1 2288/4885HSP90AB1 2730/4885NPC1 2408/4885 |
| US-20020007094-A1 | Method for producing 1-menthol | HRH4, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, PHOSPHO1 | HSP90AA1 1562/4885HSP90AB1 1651/4885NPC1 3772/4885 |
| US-20170022162-A1 | METHOD FOR MANUFACTURING OPTICALLY ACTIVE COMPOUND | C9, C5, PRMT7 | HSP90AA1 3898/4885HSP90AB1 4102/4885NPC1 1116/4885 |
| US-20020035283-A1 | Process for producing optically active alcohol | ADH1A, ADH5, ADH1C | HSP90AA1 2880/4885HSP90AB1 3304/4885NPC1 3437/4885 |
| US-20160152550-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE 2,3-DIHYDROFARNESAL | FNTB, FNTA, LSS | HSP90AA1 2813/4885HSP90AB1 2462/4885NPC1 176/4885 |
| US-20150376102-A1 | METHOD OF PRODUCING OPTICALLY-ACTIVE ALDEHYDE | ALDH3A1, ALDH1A2, ADH1A | HSP90AA1 2288/4885HSP90AB1 2730/4885NPC1 2408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.